Indeed, the reduced muscle expression of FNDC5, which is dependent on PGC-1α, has been associated with various pathological conditions, such as heart failure and obesity, suggesting the potential to counteract disorders of different origins through ERRs activation (Mozaffaritabar et al., 2024). This evidence concerns the gene PPARGC1A and obesity disorder.